Business · 01/09/2005Updated: 10/17/2026 · 1 min read
FDA Requests Comments on Simultaneous Marketing of Prescription and Over-the-Counter Drugs
Summary
The FDA is seeking public input on whether to establish a rule allowing the simultaneous marketing of prescription and over-the-counter versions of the same active ingredient, as outlined in section 503(b) of the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →